| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.19B | -2.4% |
| Gross profit | ¥0.04B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.01B | +248.3% |
| Gross margin | 19.7% | Net margin 3.6% |
| Revenue Q/Q | -13.2% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.15B | 80.3% |
| R&D | ¥0.01B | 3.9% |
| SG&A | ¥0.01B | 7.3% |
| Tax & other | ¥0.00B | 1.0% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
华测导航 ・ 新劲刚 ・ 久吾高科 ・ 光莆股份 ・ 开立医疗 ・ 彩讯股份 ・ 中达安 ・ 同和药业 ・ 扬帆新材 ・ 广和通 ・ 凯普生物 ・ 德艺文创
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies